Boston Magazine’s Top Docs 2020

Boston Magazine just released its annual listing of “Top Docs” and five of our faculty members have been recognized for this prestigious honor! Congratulations to Vaishali Sanchorawala, MD (Hematology), Gretchen Gignac, MD (Medical Oncology), Adam Lerner, MD (Medical Oncology), Kevan Hartshorn, MD (Medical Oncology) and Matthew Kulke, MD (Medical Oncology). The recognition of multiple faculty members in this way is a wonderful tribute […]

Dr. David Chui’s Hemoglobin Diagnostic Reference Laboratory at BMC provided the diagnostic genetic testing referenced in the New England Journal of Medicine.

Dr. David Chui’s Hemoglobin Diagnostic Reference Laboratory at BMC provided the diagnostic genetic testing referenced in the New England Journal of Medicine CPC presented by Dr. Ed Benz, President of Dana Farber Cancer Institute. Please click here for more information: http://www.nejm.org/doi/full/10.1056/NEJMcpc1013925

Talks

Dr. Vaishali Sanchorawala did two grand round talks at Vanderbilt University Medical Center on May 26. Hematology/Oncology Grand Rounds – “Advances in the diagnosis, prognosis and treatment of AL amyloidosis.” Cardiology Grand Rounds – “Amyloidosis – the changing landscape.”

Awards

Dr. George Murphy has been selected to receive an ASH Scholar Award beginning on July 1, 2011. Irene Roman, a postdoctoral fellow in Dr. Dominguez’ lab received a travel award to give an oral presentation entitled “CK2 is essential for heart morphogenesis in mouse development” at the Northeast Regional Meeting for the Society for Developmental […]

Publications

Meier-Ewert HK, Sanchorawala V, Berk JL, Ruberg FL. Cardiac Amyloidosis: Evolving Approach to Diagnosis and Management. Current Treatment Options Cardiovascular Medicine 2011; 13: 528-542. Sanchorawala V, Quillen K, Sloan JM, Andrea NT, Seldin DC. Bortezomib and high dose melphalan conditioning for stem cell transplantation for AL amyloidosis: a pilot study. Haematologica 2011 {Prepublished online on […]

Grants

Dr. Dominguez was awarded an AHA Grant in Aid for 3 years, $200,000 total, for a project entitled “Effect of CK2 Dysregulation on Heart Morphogenesis”. Dr. Seldin was awarded a one year grant from Link Medicine Corporation, titled “Evaluation of Link Medicine Corporation’s Compound in AL Amyloidosis” in the amount of $44,000. Dr. Zhong was […]